To note, sample 6 was classified 3+ on the PDX sample, but 2+ on the corresponding patient tumor and GLQSLPTHDPSPLQR quantification was found lower (319 amol/μg) than in other HER2-positive PDXs. The gene discussed is ERBB2; the disease is neoplasm.